By: Benzinga
Cowen and Company Reiterates Outperform Rating on Auxilium Pharmaceuticals
In a report published Monday, Cowen and Company reiterated its Outperform rating on Auxilium Pharmaceuticals (NASDAQ: AUXL ). Cowen and Company noted, “This morning in conjunction with a competitor's conference, Auxilium disclosed 2012 full year product revenues that are within the ranges of previous guidance. This is good news, as
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here